Sugammadex Amomed 100 mg/ml Injektionslösung New

Recall | Medicines | 19/08/2025

The marketing authorisation holder informed its customers on August 18, 2025, that clearly visible, white and fluffy particles were found in individual vials.  For this reason, the affected batch is being recalled.

Name of the medicinal product Sugammadex Amomed 100 mg/ml Injektionslösung
Marketing authorisation number(s) EU/1/22/1708/001
CIP code 5521778
Marketing authorisation holder AOP Orphan Pharmaceuticals GmbH
Batch number(s) SX2403A
Expiry date 10/31/2027
Classification of the recall2
Depth of recall Pharmacies
BASG reference number INS-640.001-5282
Email

Further inquiry note